Skip to Content

Vanderbilt-Ingram Cancer CenterVanderbilt-Ingram Cancer Center

 

VICC toll-free number 1-877-936-8422

Clinical Trials for Other Pediatric Cancers

3 Open Trials

Trial Type Protocol No. &
Open Date
Summary

Other

VICCPED0710

03/16/2007

Long Term Effects for Childhood Cancer Survivors

Other

COGALTE03N1

04/20/2005

Key Adverse Events after Childhood Cancer

Treatment

VICCNCPED1414

04/24/2014

HLA-haploidentical Related Marrow Grafts for the Treatment of Primary Immunodeficiencies and other Nonmalignant Disorders Using Conditioning with Low-Dose Cyclophosphamide, TBI and Fludarabine; Postgrafting Immunosuppression will Consist of a Single Low Dose of Cyclophosphamide, MMF and Tacrolimus